• 1
    Belle SH, Detre KM. Report from the Pitt–UNOS Liver Transplant Registry. Transplant Proc 1993; 25: 11371142.
  • 2
    The European Liver Transplant Registry Report. Villejuif: Hôpital Paul Brousse, December, 1994.
  • 3
    Nakhleh RE, Schwarzenberg SJ, Bloomer J, Payne W, Snover DC. The pathology of liver grafts surviving beyond one year. HEPATOLOGY 1990; 3: 465470.
  • 4
    Backman L, Gibbs J, Levy M, McMillan R, Holman M, Husberg B, Goldstein R, et al. Late graft loss after liver transplantation: a study of 434 consecutive patients. Transplant Proc 1993; 25: 11111112.
  • 5
    McCaughan GW, O'Brien E, Sheil AGR. A follow–up of 53 adult patients alive beyond 2 years following liver transplantation. J Gastroenterol Hepatol 1993; 8: 569573.
  • 6
    Pappo O, Ramos H, Starzl T, Fung J, Demetris A. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 1995; 19: 192206.
  • 7
    Review Guideline. Summary of 1993 WHO/ISH guidelines for the management of mild hypertension. Br Med J 1994; 308: 470473.
  • 8
    Portmann B, Neuberger JM. Disease recurrence (viral and other disorders). In: WilliamsR, PortmannB, TanKG, eds. The Practice of Liver Transplantation. London and Edinburgh; Churchill Livingstone, 1995; 245245.
  • 9
    Gane EJ, Portmann BC, Smith HM, Tibbs CJ, Naoumov NV, Williams R. Hepatitis C virus infection after liver transplantation (OLT) is associated with severe graft disease. J Hepatol 1995; 22: 21.
  • 10
    Weinstein JS, Poterucha JJ, Zein N, Wiesner RH, Persing DH, Rakela J. Epidemiology and natural history of hepatitis C infections in liver transplant recipients. J Hepatol 1995; 22 (suppl 1): 154159.
  • 11
    Wright HL, Bou–Abboud C, Hassanein T, Block GD, Demetris AJ, Starzl TE, Van Thiel DH. Disease recurrence following transplantation for autoimmune chronic active liver disease. Transplantation 1992; 53: 136139.
  • 12
    Portmann B, Popper H, Neuberger J, Williams R. Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. Gastroenterology 1985; 88: 17771790.
  • 13
    Neuberger JM, Portmann B, Macdougall B, Calne RY, Williams R. Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 1982; 306: 14.
  • 14
    Polson R, Portmann B, Neuberger JM, Calne RY, Williams R. Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Gastroenterology 1989; 97: 715725.
  • 15
    Balan V, Batts KP, Porayko MK, Krom RAF, Ludwig J, Wiesner RH. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. HEPATOLOGY 1993; 18: 13921398.
  • 16
    Hubscher SG, Elias E, Buckels JAC, Mayer D, McMaster P, Neuberger JM. Primary biliary cirrhosis: histological evidence of disease recurrence after liver transplantation. J Hepatol 1993; 18: 173184.
  • 17
    Wong P, Portmann B, O'Grady J, Devlin JJ, Hegarty JE, Tan K–C, Williams R. Recurrence of primary biliary cirrhosis after liver transplantation following FK506 based immunosuppression. J Hepatol 1993; 17: 284287.
  • 18
    Devlin J, Slapak G, Portmann B, Williams R. Immunosuppression withdrawal in longterm liver recipients [Abstract]. HEPATOLOGY 1994; 20: 124A.
  • 19
    Calne RY. A new technique for biliary drainage in orthotopic liver transplantation utilising the gallbladder as a pedicle graft conduit between the donor and recipient common bile ducts. Ann Surg 1977; 184: 605609.
  • 20
    McMaster P, Walton RM, White DG, Medd RK, Syrakos TP. The influence of ischaemia on the biliary tract. Br J Surg 1980; 67: 321324.
  • 21
    Harrison RF, Davies MH, Neuberger JM, Hubscher SG. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? HEPATOLOGY 1994; 20: 356361.
  • 22
    Brixto C, Wall SD, Ferrell L. Evidence for recurrence of primary sclerosing cholangitis after orthotopic liver transplantation [Abstract]. HEPATOLOGY 1993; 18: 325 A.
  • 23
    Li S, Stratta RJ, Langnas AN, Wood RP, Marujo W, Shaw BW. Diffuse biliary tract injury after orthotopic liver transplantation. Am J Surg 1992; 164: 536540.
  • 24
    Sebagh M, Farges O, Kalil A, Samuel D, Bismuth H, Reynes M. Sclerosing cholangitis following human orthotopic liver transplantation. Am J Surg Pathol 1995; 19: 8190.
  • 25
    Naber AHJ, Van Haelst U, Yap SH. Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non–cirrhotic patients. J Hepatol 1991; 12: 9499.
  • 26
    Katzka DA, Saul SH, Jorkasky D, Sigal H, Reynolds JC, Soloway RD. Azathioprine and hepatic veno–occlusive disease in renal transplant recipients. Gastroenterology 1986; 90: 446454.
  • 27
    Gane E, Portmann B, Saxena R, Wong P, Ramage J, Williams R. Nodular regenerative hyperplasia of the liver graft after liver transplantation. HEPATOLOGY 1994; 20: 8894.
  • 28
    Wanless I, Godwin T, Allen F, Feder A. Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative venopathy. Medicine 1980; 59: 367379.
  • 29
    Maia de Souza J, Portmann B, Williams R. Nodular regenerative hyperplasia of the liver and the Budd–Chiari syndrome. HEPATOLOGY 1991; 12: 2835.
  • 30
    Haboubi N, Ali H, Whitwell H, Ackrill P. Role of endothelial cell injury in the spectrum of azathioprine induced liver disease after renal transplant: light microscopy and ultrastructural observations. Am J Gastroenterol 1988; 83: 256261.
  • 31
    Mazzaferro V, Porter KA, Scotti–Foglieni CL, Venkataramanan R, Makowka L, Rossaro L, Francavilla A, et al. The hepatotrophic influence of cyclosporin. Surgery 1990; 107: 533539.
  • 32
    Francavilla A, Barone M, Todo S, Zeng Q, Porter KA, Starzl TE. Augmentation of rat liver regeneration by FK506 compared with cyclosporin. Lancet 1989; 2: 12481249.
  • 33
    Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical Treatment of HCC; experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15: 270285.
  • 34
    McPeake JR, O'Grady J, Zaman S, Portmann B, Wight DGD, Tan KC, Calne RY, et al. Liver transplantation for primary hepatocellular carcinoma: tumour size and number determine outcome. J Hepatol 1993; 18: 226234.
  • 35
    Sheil AGR. Malignancy following liver transplantation–a report from the Australian combined Liver Transplant Registry. Transpl Proc 1995; 27: 1247.